965 related articles for article (PubMed ID: 26065721)
21. Is cachexia associated with chemotherapy toxicities in gastrointestinal cancer patients? A prospective study.
da Rocha IMG; Marcadenti A; de Medeiros GOC; Bezerra RA; Rego JFM; Gonzalez MC; Fayh APT
J Cachexia Sarcopenia Muscle; 2019 Apr; 10(2):445-454. PubMed ID: 30924270
[TBL] [Abstract][Full Text] [Related]
22. Cancer-associated malnutrition, cachexia and sarcopenia: the skeleton in the hospital closet 40 years later.
Ryan AM; Power DG; Daly L; Cushen SJ; Ní Bhuachalla Ē; Prado CM
Proc Nutr Soc; 2016 May; 75(2):199-211. PubMed ID: 26786393
[TBL] [Abstract][Full Text] [Related]
23. Loss of skeletal muscle mass during neoadjuvant treatments correlates with worse prognosis in esophageal cancer: a retrospective cohort study.
Järvinen T; Ilonen I; Kauppi J; Salo J; Räsänen J
World J Surg Oncol; 2018 Feb; 16(1):27. PubMed ID: 29433514
[TBL] [Abstract][Full Text] [Related]
24. Body composition and its association with cardiometabolic risk factors in the elderly: a focus on sarcopenic obesity.
Chung JY; Kang HT; Lee DC; Lee HR; Lee YJ
Arch Gerontol Geriatr; 2013; 56(1):270-8. PubMed ID: 23079031
[TBL] [Abstract][Full Text] [Related]
25. Sarcopenia among hospitalized patients - A cross-sectional study.
Sousa AS; Guerra RS; Fonseca I; Pichel F; Amaral TF
Clin Nutr; 2015 Dec; 34(6):1239-44. PubMed ID: 25577017
[TBL] [Abstract][Full Text] [Related]
26. Discriminating sarcopenia in overweight/obese male patients with heart failure: the influence of body mass index.
Fonseca GWPD; Dos Santos MR; de Souza FR; Takayama L; Rodrigues Pereira RM; Negrão CE; Alves MNN
ESC Heart Fail; 2020 Feb; 7(1):84-91. PubMed ID: 31877587
[TBL] [Abstract][Full Text] [Related]
27. Clinical Implications of Sarcopenic Obesity in Cancer.
Carneiro IP; Mazurak VC; Prado CM
Curr Oncol Rep; 2016 Oct; 18(10):62. PubMed ID: 27541923
[TBL] [Abstract][Full Text] [Related]
28. Sarcopenia/Muscle Mass is not a Prognostic Factor for Short- and Long-Term Outcome After Esophagectomy for Cancer.
Grotenhuis BA; Shapiro J; van Adrichem S; de Vries M; Koek M; Wijnhoven BP; van Lanschot JJ
World J Surg; 2016 Nov; 40(11):2698-2704. PubMed ID: 27272482
[TBL] [Abstract][Full Text] [Related]
29. Effect of Body Mass Index- and Actual Weight-Based Neoadjuvant Chemotherapy Doses on Pathologic Complete Response in Operable Breast Cancer.
Raman R; Mott SL; Schroeder MC; Phadke S; El Masri J; Thomas A
Clin Breast Cancer; 2016 Dec; 16(6):480-486. PubMed ID: 27431461
[TBL] [Abstract][Full Text] [Related]
30. Associations of Sarcopenic Obesity and Dynapenic Obesity with Bone Mineral Density and Incident Fractures Over 5-10 Years in Community-Dwelling Older Adults.
Scott D; Chandrasekara SD; Laslett LL; Cicuttini F; Ebeling PR; Jones G
Calcif Tissue Int; 2016 Jul; 99(1):30-42. PubMed ID: 26939775
[TBL] [Abstract][Full Text] [Related]
31. Sarcopenia, sarcopenic obesity and inflammation: Results from the 1999-2004 National Health and Nutrition Examination Survey.
Batsis JA; Mackenzie TA; Jones JD; Lopez-Jimenez F; Bartels SJ
Clin Nutr; 2016 Dec; 35(6):1472-1483. PubMed ID: 27091774
[TBL] [Abstract][Full Text] [Related]
32. Sarcopenia, sarcopenic obesity, and functional impairments in older adults: National Health and Nutrition Examination Surveys 1999-2004.
Batsis JA; Mackenzie TA; Lopez-Jimenez F; Bartels SJ
Nutr Res; 2015 Dec; 35(12):1031-9. PubMed ID: 26472145
[TBL] [Abstract][Full Text] [Related]
33. Skeletal Muscle Measures as Predictors of Toxicity, Hospitalization, and Survival in Patients with Metastatic Breast Cancer Receiving Taxane-Based Chemotherapy.
Shachar SS; Deal AM; Weinberg M; Nyrop KA; Williams GR; Nishijima TF; Benbow JM; Muss HB
Clin Cancer Res; 2017 Feb; 23(3):658-665. PubMed ID: 27489287
[TBL] [Abstract][Full Text] [Related]
34. Is sarcopenia and sarcopenic obesity associated with clinical and pathological outcomes in patients undergoing radical nephroureterectomy?
Kocher NJ; Jafri S; Balabhadra S; Lehman E; Gardner J; Vijay K; Sarwani N; Raman JD
Urol Oncol; 2018 Apr; 36(4):156.e17-156.e22. PubMed ID: 29276063
[TBL] [Abstract][Full Text] [Related]
35. Body Composition by Computed Tomography as a Predictor of Toxicity in Patients With Renal Cell Carcinoma Treated With Sunitinib.
Cushen SJ; Power DG; Teo MY; MacEneaney P; Maher MM; McDermott R; O'Sullivan K; Ryan AM
Am J Clin Oncol; 2017 Feb; 40(1):47-52. PubMed ID: 24685884
[TBL] [Abstract][Full Text] [Related]
36. Sarcopenia in overweight and obese patients is a predictive factor for postoperative complication in gastric cancer: A prospective study.
Lou N; Chi CH; Chen XD; Zhou CJ; Wang SL; Zhuang CL; Shen X
Eur J Surg Oncol; 2017 Jan; 43(1):188-195. PubMed ID: 27692536
[TBL] [Abstract][Full Text] [Related]
37. Chronic kidney disease and high eGFR according to body composition phenotype in adults with normal BMI.
Hyun YY; Lee KB; Rhee EJ; Park CY; Chang Y; Ryu S
Nutr Metab Cardiovasc Dis; 2016 Dec; 26(12):1088-1095. PubMed ID: 27776918
[TBL] [Abstract][Full Text] [Related]
38. Sarcopenia Is Common in Overweight Patients with Inflammatory Bowel Disease and May Predict Need for Surgery.
Adams DW; Gurwara S; Silver HJ; Horst SN; Beaulieu DB; Schwartz DA; Seidner DL
Inflamm Bowel Dis; 2017 Jul; 23(7):1182-1186. PubMed ID: 28410342
[TBL] [Abstract][Full Text] [Related]
39. Body Composition as a Prognostic Factor of Neoadjuvant Chemotherapy Toxicity and Outcome in Patients with Locally Advanced Gastric Cancer.
Palmela C; Velho S; Agostinho L; Branco F; Santos M; Santos MP; Oliveira MH; Strecht J; Maio R; Cravo M; Baracos VE
J Gastric Cancer; 2017 Mar; 17(1):74-87. PubMed ID: 28337365
[TBL] [Abstract][Full Text] [Related]
40. Sarcopenic Obesity and Its Temporal Associations With Changes in Bone Mineral Density, Incident Falls, and Fractures in Older Men: The Concord Health and Ageing in Men Project.
Scott D; Seibel M; Cumming R; Naganathan V; Blyth F; Le Couteur DG; Handelsman DJ; Waite LM; Hirani V
J Bone Miner Res; 2017 Mar; 32(3):575-583. PubMed ID: 27736026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
